Improvement of spontaneous speech in early stage Alzheimer's with rivastigmine.

about

Connected Speech in Neurodegenerative Language Disorders: A Review Aspects of communication in Alzheimer's disease: clinical features and treatment options.

P2860

Q30360744-122FF827-83F4-4522-8543-563ED7F1FA96 Q38092302-2C93D754-E8F2-40E6-A4E0-234332428CDD

P2860

Improvement of spontaneous speech in early stage Alzheimer's with rivastigmine.

Item

http://www.wikidata.org/entity/Q46158129

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Improvement of spontaneous speech in early stage Alzheimer's with rivastigmine.

@en

Improvement of spontaneous speech in early stage Alzheimer's with rivastigmine.

@nl

type

Item

label

Improvement of spontaneous speech in early stage Alzheimer's with rivastigmine.

@en

Improvement of spontaneous speech in early stage Alzheimer's with rivastigmine.

@nl

prefLabel

Improvement of spontaneous speech in early stage Alzheimer's with rivastigmine.

@en

Improvement of spontaneous speech in early stage Alzheimer's with rivastigmine.

@nl

P1476

Improvement of spontaneous speech in early stage Alzheimer's with rivastigmine.

@en

P2093

E G Visch Brink

http://www.w3.org/2001/XMLSchema#string

F Van Harskamp

http://www.w3.org/2001/XMLSchema#string

J W M Krulder

http://www.w3.org/2001/XMLSchema#string

T J M Van der Cammen

http://www.w3.org/2001/XMLSchema#string

T Rietveld

http://www.w3.org/2001/XMLSchema#string

W Van Rhee Temme

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease. A systematic review.

Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment.

Alzheimer's disease and Parkinson's disease: comparison of speech and language alterations.

Age at disease onset and pattern of cognitive impairment in probable Alzheimer's disease.

Dementia of the Alzheimer type. An inventory of diagnostic clinical features.

A new rating scale for Alzheimer's disease.

The Global Deterioration Scale for assessment of primary degenerative dementia

P2888

s12603-009-0007-z

P304

34-38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12603-009-0007-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23799002

http://www.w3.org/2001/XMLSchema#string

P698

19151906

http://www.w3.org/2001/XMLSchema#string

Improvement of spontaneous speech in early stage Alzheimer's with rivastigmine.

about

P2860

P2860

Improvement of spontaneous speech in early stage Alzheimer's with rivastigmine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698